Drugs / PF-04878691
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00810758 | Jan → Nov 2009 | hepatitis C virus infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04878691 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00810758 ↗ |
| Route | Oral | “Oral solution, 3mg, twice weekly, 2 weeks” NCT00810758 ↗ |